Drépanocytose : génétique et épidémiologie.

Abstract

Sickle cell disease is a major public health problem with other hemoglobin diseases, the aim of our study was to determine the epidemiological and biological profile of sickle cell. Through a study of an analysis of a homozygous (S/S) sickle cell disease in the Oran region. The blood count of sickle cell patients (S / S) is as follows: the red blood cells (4.675x106), hemoglobin estimated (7.63), the VGM estimated (59.81) and finally the TCMH estimated at (25.8). Currently, sickle-cell anemia is not cured and the only available treatments are used to mitigate or prevent the pain caused by this disease. Treatments include analgesics, blood transfusions and bone marrow transplants.